SPP1 and breast carcinoma: Finally, the elevation of OPN in post-baseline plasma samples, found in both recurrent and non-recurrent patients (some of whom might have recurred at a later date), suggests that there may be a role for serial measurement of plasma OPN to monitor for recurrence, in the setting of early breast cancer.